Gene · 4085
Papers3,516
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,516
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ribonucleotide reductase regulatory subunit M2 (RRM2) as a potential sero-diagnostic biomarker in non-small cell lung cancer. | PLoS One | 2023 | 37699023 | PubTator, text mining | PubMed |
Cyclin dependent kinase inhibitor 3 (CDKN3) upregulation is associated with unfavorable prognosis in clear cell renal cell carcinoma and shapes tumor immune microenvironment: A bioinformatics analysis. | Medicine (Baltimore) | 2023 | 37682177 | PubTator, text mining | PubMed |
| The potential role of CDC20 in tumorigenesis, cancer progression and therapy: A narrative review. | Medicine (Baltimore) | 2023 | 37682144 | PubTator, text mining | PubMed |
| The regulatory role of cancer stem cell marker gene CXCR4 in the growth and metastasis of gastric cancer. | NPJ Precis Oncol | 2023 | 37679408 | PubTator, text mining | PubMed |
| CENP-E activation by Aurora A and B controls kinetochore fibrous corona disassembly. | Nat Commun | 2023 | 37658044 | PubTator, text mining | PubMed |
| Cornelia de Lange Syndrome mutations in SMC1A cause cohesion defects in yeast. | Genetics | 2023 | 37650609 | PubTator, text mining | PubMed |
| Mad2B forms a complex with Cdc20, Cdc27, Rev3 and Rev1 in response to cisplatin-induced DNA damage. | Korean J Physiol Pharmacol | 2023 | 37641805 | PubTator, text mining | PubMed |
| Genetic enhancers of partial PLK1 inhibition reveal hypersensitivity to kinetochore perturbations. | PLoS Genet | 2023 | 37639469 | PubTator, text mining | PubMed |
| Identification of NOX4 as a New Biomarker in Hepatocellular Carcinoma and Its Effect on Sorafenib Therapy. | Biomedicines | 2023 | 37626693 | PubTator, text mining | PubMed |
| TRAIP resolves DNA replication-transcription conflicts during the S-phase of unperturbed cells. | Nat Commun | 2023 | 37604812 | PubTator, text mining | PubMed |
| Identification of functional genes regulating gastric cancer progression using integrated bioinformatics analysis. | World J Clin Cases | 2023 | 37583848 | PubTator, text mining | PubMed |
| High SGO2 predicted poor prognosis and high therapeutic value of lung adenocarcinoma and promoted cell proliferation, migration, invasion, and epithelial-to-mesenchymal transformation. | J Cancer | 2023 | 37576392 | PubTator, text mining | PubMed |
| High-density lipoprotein regulates angiogenesis by long non-coding RNA HDRACA. | Signal Transduct Target Ther | 2023 | 37574469 | PubTator, text mining | PubMed |
| Prognostic and immunomodulatory roles of schizophrenia-associated genes HTR2A, COMT, and PRODH in pan-cancer analysis and glioma survival prediction model. | Front Immunol | 2023 | 37564635 | PubTator, text mining | PubMed |
| Androgen receptor suppresses lung cancer invasion and increases cisplatin response via decreasing TPD52 expression. | Int J Biol Sci | 2023 | 37564195 | PubTator, text mining | PubMed |
| Identification of distinct gene co-expression modules and specific hub genes in skin lesions of atopic dermatitis and psoriasis by WGCNA. | FEBS Open Bio | 2023 | 37548115 | PubTator, text mining | PubMed |
| Application of multiple machine learning approaches to determine key pyroptosis molecules in type 2 diabetes mellitus. | Front Endocrinol (Lausanne) | 2023 | 37538791 | PubTator, text mining | PubMed |
| Construction of lncRNA-m6A gene-mRNA regulatory network to identify m6A-related lncRNAs associated with the progression of lung adenocarcinoma. | BMC Pulm Med | 2023 | 37537521 | PubTator, text mining | PubMed |
| Medicinal Characteristics of Withania somnifera L. in Colorectal Cancer Management. | Pharmaceuticals (Basel) | 2023 | 37513827 | PubTator, text mining | PubMed |
The Role of Mitochondrial Dynamics and Mitotic Fission in Regulating the Cell Cycle in Cancer and Pulmonary Arterial Hypertension: Implications for Dynamin-Related Protein 1 and Mitofusin2 in Hyperproliferative Diseases. | Cells | 2023 | 37508561 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4085/papers?page=11